At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
The MetaNeb® Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of The MetaNeb® System to Reduce Atelectasis Assessed by Chest X-ray
In Brief
A clinical study evaluating The MetaNeb® System for Atelectasis. Completed, enrolled 8 participants across 1 site.
Detailed Summary
To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in the study will receive therapy with The MetaNeb® System following the labeled instructions for the device. Details of the treatment including duration and frequency will be defined in treatment procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtelectasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartSep 2016
Primary CompletionAug 2017
TodayJul 2026
First PostedAug 18, 2016
Enrollment StartSep 1, 2016
Primary CompletionAug 17, 2017
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.9 years ago
Interventions
The MetaNeb® Systemdevice